Similarly, Levy and colleagues successfully transfected NK cells in vitro with CXCR4 mRNA via electroporation, suggesting that CXCR4 overexpression is a promising approach to tackle tumors in the bone marrow, such as myeloma and leukemia [53]. The gene discussed is CXCR4; the disease is plasma cell myeloma.